I - Cancer cachexia: Pathophysiological mechanisms

David B. Gough*, Steven D. Heys, Oleg Eremin

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

14 Citations (Scopus)

Abstract

Cancer cachexia is a condition characterized by anorexia, progressive tissue wasting and loss of weight, It has been estimated that cachexia may be a major contributor to death in up to two-thirds of patients with cancer, Cachexia is associated with a complex array of organ and tissue abnormalities, such as skeletal muscle atrophy and weakness, accelerated loss of fat stores and visceral organ atrophy, the combination of which may predispose patients undergoing surgery to wound infection and breakdown, respiratory complications, prolonged hospital stay and rehabilitation) Detailed analyses of immune function, haematology and biochemistry in affected patients frequently reveal anergy, anaemia, hypoalbuminaemia, lactic acidaemia, hyperlipidaemia and glucose intolerance. In many cases, the external manifestations of this process serve to alert clinicians to the possibility of an underlying malignancy in a newly referred patient.
Original languageEnglish
Pages (from-to)192-196
Number of pages5
JournalEuropean Journal of Surgical Oncology
Volume22
Issue number2
DOIs
Publication statusPublished - 1 Apr 1996

Fingerprint

Dive into the research topics of 'I - Cancer cachexia: Pathophysiological mechanisms'. Together they form a unique fingerprint.

Cite this